| scholarly article | Q13442814 |
| P2093 | author name string | John R Couchman | |
| Hinke A B Multhaupt | |||
| Atsuko Yoneda | |||
| Maria E Lendorf | |||
| P2860 | cites work | Glypicans | Q21183908 |
| Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma | Q73144573 | ||
| High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery | Q73965564 | ||
| Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice | Q73977149 | ||
| Glypican-3 expression in primary and recurrent ovarian carcinomas | Q80506061 | ||
| Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary | Q80709350 | ||
| Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype | Q83198017 | ||
| Ovarian cancer | Q84605146 | ||
| Syndecan-2 regulates cell migration in colon cancer cells through Tiam1-mediated Rac activation | Q84984670 | ||
| Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome | Q24320198 | ||
| Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer | Q24550887 | ||
| Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component | Q24621174 | ||
| Heparan sulphate synthetic and editing enzymes in ovarian cancer | Q24653774 | ||
| Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4 | Q24681644 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells | Q28206492 | ||
| Solution Structure of a Syndecan-4 Cytoplasmic Domain and Its Interaction with Phosphatidylinositol 4,5-Bisphosphate | Q28270480 | ||
| Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer | Q28275904 | ||
| Heparan Sulfate Proteoglycans as Regulators of Fibroblast Growth Factor-2 Receptor Binding in Breast Carcinomas | Q28344801 | ||
| Control of morphology, cytoskeleton and migration by syndecan-4 | Q28568063 | ||
| The loss of glypican-3 induces alterations in Wnt signaling | Q28575434 | ||
| Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding | Q28590274 | ||
| Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4 | Q28591320 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world | Q29614969 | ||
| Oncogenic pathway signatures in human cancers as a guide to targeted therapies | Q29615526 | ||
| Genomic and transcriptional aberrations linked to breast cancer pathophysiologies | Q29619120 | ||
| Heparan sulphate proteoglycans fine-tune mammalian physiology | Q29619329 | ||
| Order out of chaos: assembly of ligand binding sites in heparan sulfate | Q29620085 | ||
| Transmembrane signaling proteoglycans | Q30390527 | ||
| Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer | Q33219573 | ||
| ABC of breast diseases: breast cancer | Q33818080 | ||
| Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer | Q33845160 | ||
| Frequent silencing of the GPC3 gene in ovarian cancer cell lines | Q33852778 | ||
| Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas. | Q33890039 | ||
| Heparan sulfate proteoglycan syndecan promotes axonal and myotube guidance by slit/robo signaling | Q34294737 | ||
| The sweet and sour of cancer: glycans as novel therapeutic targets | Q34439560 | ||
| Protein kinase C regulates the recruitment of syndecan-4 into focal contacts | Q34452929 | ||
| Loss of heterozygosity on chromosome XP22.2-p22.13 and Xq26.1-q27.1 in human breast carcinomas | Q34656153 | ||
| Modelling breast cancer: one size does not fit all. | Q34667643 | ||
| Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis | Q35098091 | ||
| Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma. | Q35189704 | ||
| Pathology of ovarian carcinoma | Q35213220 | ||
| Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study | Q38446888 | ||
| Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. | Q39924415 | ||
| Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells | Q40297851 | ||
| Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6. | Q40378604 | ||
| Syndecan-2 overexpression induces osteosarcoma cell apoptosis: Implication of syndecan-2 cytoplasmic domain and JNK signaling. | Q40413283 | ||
| OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. | Q41120310 | ||
| Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells | Q41129821 | ||
| Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements | Q41871371 | ||
| Syndecan-4 regulates localization, activity and stability of protein kinase C-alpha | Q42156901 | ||
| Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer | Q42499457 | ||
| Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary | Q42849233 | ||
| Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. | Q43424801 | ||
| Reduced Expression of Syndecan‐1 Affects Metastatic Potential and Clinical Outcome in Patients with Colorectal Cancer | Q43777017 | ||
| Glypican-3 expression is silenced in human breast cancer | Q43796931 | ||
| Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model. | Q43872108 | ||
| Glypican-3 expression in clear cell adenocarcinoma of the ovary | Q44268931 | ||
| Relationship between long durations and different regimens of hormone therapy and risk of breast cancer | Q44489759 | ||
| A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase. | Q44816865 | ||
| Epidemiology and risk assessment for ovarian cancer | Q45142084 | ||
| Opposing activities of Dally-like glypican at high and low levels of Wingless morphogen activity | Q47070543 | ||
| Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays | Q51602472 | ||
| Heparan sulfate proteoglycans at a glance | Q51985397 | ||
| Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer | Q53359239 | ||
| A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary | Q53404100 | ||
| Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells | Q53669222 | ||
| High performance capillary electrophoresis method to characterize heparin and heparan sulfate disaccharides | Q71744256 | ||
| Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma | Q35441324 | ||
| Syndecans: proteoglycan regulators of cell-surface microdomains? | Q35611355 | ||
| Breast cancer biomarkers and molecular medicine: part II. | Q35680309 | ||
| Syndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix | Q35828567 | ||
| Functions of heparan sulfate proteoglycans in cell signaling during development | Q35962679 | ||
| Utilizing prognostic and predictive factors in breast cancer | Q36046256 | ||
| Origins and molecular pathology of ovarian cancer | Q36068263 | ||
| Significance of Heparanase in Cancer and Inflammation | Q36101233 | ||
| The etiology of alcohol-induced breast cancer | Q36213159 | ||
| OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. | Q36255453 | ||
| Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells | Q36321055 | ||
| Breast cancer biomarkers. | Q36342545 | ||
| Diagnosis and management of epithelial ovarian cancer | Q36493937 | ||
| Molecular pathology of epithelial ovarian cancer | Q36507679 | ||
| Interactions between heparan sulfate and proteins: the concept of specificity | Q36552851 | ||
| Extracellular matrix of ovarian tumors. | Q36582459 | ||
| Transmembrane domains of the syndecan family of growth factor coreceptors display a hierarchy of homotypic and heterotypic interactions | Q36696352 | ||
| Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis | Q36868408 | ||
| Molecular subtyping of breast cancer: opportunities for new therapeutic approaches | Q36980338 | ||
| Synergistic control of cell adhesion by integrins and syndecans. | Q36986535 | ||
| Syndecan-1: a dynamic regulator of the myeloma microenvironment | Q37008599 | ||
| Predictive markers in breast cancer--the present | Q37048779 | ||
| The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation. | Q37228526 | ||
| Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion. | Q37475741 | ||
| Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis. | Q37494563 | ||
| Interactions between heparan sulfate and proteins-design and functional implications | Q37543699 | ||
| Chapter 1. Focal adhesions: new angles on an old structure. | Q37600445 | ||
| Syndecan signaling: when, where and why? | Q37677440 | ||
| Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer | Q37740951 | ||
| Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate | Q37772524 | ||
| Proteoglycans in health and disease: the multiple roles of syndecan shedding | Q37788814 | ||
| Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. | Q37788815 | ||
| The heparanase system and tumor metastasis: is heparanase the seed and soil? | Q37838802 | ||
| Ovarian Cancer Management: the role of imaging and diagnostic challenges. | Q37851707 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| heparan sulfate proteoglycans | Q66589633 | ||
| P304 | page(s) | 9-21 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Journal of Histochemistry and Cytochemistry | Q1523992 |
| P1476 | title | Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans | |
| P478 | volume | 60 |
| Q36481630 | An Introduction to Proteoglycans and Their Localization |
| Q41134603 | An oncolytic adenovirus regulated by a radiation‐inducible promoter selectively mediates hSulf‐1 gene expression and mutually reinforces antitumor activity of I131‐metuximab in hepatocellular carcinoma |
| Q42672908 | Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis |
| Q54096113 | Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer |
| Q35078198 | Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells |
| Q39084303 | Characterization of the attachment mechanisms of tissue-derived cell lines to blood-compatible polymers. |
| Q88721158 | Deep Sequencing of Complex Proteoglycans: A Novel Strategy for High Coverage and Site-specific Identification of Glycosaminoglycan-linked Peptides |
| Q26797302 | Determinants of Glycosaminoglycan (GAG) Structure |
| Q91302049 | Diet, menopause and the risk of ovarian, endometrial and breast cancer |
| Q96134541 | Early diagnosis of breast and ovarian cancers by body fluids circulating tumor-derived exosomes |
| Q91962415 | Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine |
| Q46121051 | Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells. |
| Q54995051 | Glycosaminoglycans and Proteoglycans. |
| Q49459657 | HOXD-AS1 promotes cell proliferation, migration and invasion through miR-608/FZD4 axis in ovarian cancer |
| Q37105315 | Heparan sulfate and heparanase as modulators of breast cancer progression |
| Q41314469 | Heparan sulfate deficiency in autistic postmortem brain tissue from the subventricular zone of the lateral ventricles |
| Q38256873 | Heparan sulfate in the regulation of neural differentiation and glioma development |
| Q53121884 | Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells |
| Q58126502 | Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p |
| Q47147401 | Mammalian sterile 20-like kinase 1 expression and its prognostic significance in patients with breast cancer. |
| Q42777464 | Mass spectral profiling of glycosaminoglycans from histological tissue surfaces |
| Q64079499 | Ovarian cancer in the world: epidemiology and risk factors |
| Q37423017 | Perimenopause Amelioration of a TCM Recipe Composed of Radix Astragali, Radix Angelicae Sinensis, and Folium Epimedii: An In Vivo Study on Natural Aging Rat Model. |
| Q34323606 | Progesterone – promoter or inhibitor of breast cancer |
| Q64094448 | Prognostic role of Tif1γ expression and circulating tumor cells in patients with breast cancer |
| Q44411448 | Prognostic significance of mammalian sterile 20-like kinase 1 in breast cancer |
| Q35599740 | Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors. |
| Q26772304 | Proteoglycans in liver cancer |
| Q42360066 | Syndecan 4 regulation of PDK1-dependent Akt activation |
| Q90580142 | The exostosin family of glycosyltransferases: mRNA expression profiles and heparan sulphate structure in human breast carcinoma cell lines |
| Q34031745 | The motile breast cancer phenotype roles of proteoglycans/glycosaminoglycans |
| Q33354119 | The mutual impact of syndecan-1 and its glycosaminoglycan chains--a multivariable puzzle |
| Q26851991 | The role of behavior in translational models for psychopathology: Functionality and dysfunctional behaviors |
Search more.